查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944263

全球戒菸和尼古丁成癮治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Smoking Cessation and Nicotine De-Addiction Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計戒菸和尼古丁成癮治療市場規模將從 2025 年的 364.6 億美元成長到 2034 年的 907.3 億美元，2026 年至 2034 年的複合年成長率為 10.66%。

隨著公共衛生措施的推進和人們對吸菸危害認知的不斷提高，戒菸和尼古丁成癮治療市場正經歷著模式轉移，對有效戒菸方案的需求日益成長。隨著越來越多的人尋求戒菸，尼古丁替代療法（NRT）、處方藥和行為支持計畫的市場正在擴大。吸菸相關健康問題的日益增加進一步推動了這一成長，促使各國政府和醫療機構加大對綜合戒菸計畫的投入，為尋求戒菸的人們提供支持和資源。

此外，數位健康技術的興起正在改變戒菸支持的格局。行動應用程式和線上平台正成為為戒菸者提供個人化支援、進度監控和激勵的寶貴工具。這些數位解決方案通常融合了行為科學原理，為使用者提供個人化的策略來應對菸癮和誘因。隨著技術的進步，人工智慧和機器學習的融入將進一步提升這些平台的效能，並為使用者提供更精準的介入和支援。

此外，電子菸和加熱菸草製品等替代尼古丁輸送系統的日益普及正在重塑戒菸市場。儘管這些產品通常被宣傳為危害較小的替代品，但它們仍然構成公共衛生挑戰。隨著監管機構評估這些替代方案的長期影響，戒菸市場必須做出調整，提供能夠滿足不同戒菸者多樣化需求的全面解決方案。因此，在創新、技術進步以及旨在改善公共衛生狀況的合作努力的推動下，戒菸和尼古丁成癮治療市場有望迎來顯著成長。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球戒菸和尼古丁成癮治療市場（按類型分類）

  • 市場分析、洞察與預測
  • 尼古丁替代療法
  • 藥物治療
  • 電子菸

5. 全球戒菸和尼古丁成癮治療市場（按形式分類）

  • 市場分析、洞察與預測
  • 膠
  • 吸入器
  • 藥片
  • 其他

6. 全球戒菸和尼古丁成癮治療市場（依分銷管道分類）

  • 市場分析、洞察與預測
  • 醫院藥房
  • 線上
  • 藥局和零售藥房

7. 全球戒菸和尼古丁成癮治療市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Rusan Pharma Ltd
    • Dr. Reddy'S Laboratories Ltd
    • Imperial Brands Plc
    • Zydus Group
    • British American Tobacco Plc
    • Perrigo Company Plc
    • Johnson And Johnson Inc
    • Njoy LLC
    • Cipla Ltd
    • GlaxoSmithKline Plc
簡介目錄
Product Code: VMR11218851

The Smoking Cessation and Nicotine De-Addiction Market size is expected to reach USD 90.73 Billion in 2034 from USD 36.46 Billion (2025) growing at a CAGR of 10.66% during 2026-2034.

The smoking cessation and nicotine de-addiction market is witnessing a paradigm shift as public health initiatives and growing awareness of the dangers of smoking drive demand for effective cessation solutions. With an increasing number of individuals seeking to quit smoking, the market for nicotine replacement therapies (NRTs), prescription medications, and behavioral support programs is expanding. This growth is further fueled by the rising prevalence of smoking-related health issues, prompting governments and healthcare organizations to invest in comprehensive smoking cessation programs that provide support and resources for individuals looking to quit.

Moreover, the advent of digital health technologies is transforming the smoking cessation landscape. Mobile applications and online platforms are emerging as valuable tools that offer personalized support, tracking, and motivation for individuals on their journey to quit smoking. These digital solutions often incorporate behavioral science principles, providing users with tailored strategies to manage cravings and triggers. As technology continues to evolve, the integration of artificial intelligence and machine learning into these platforms will enhance their effectiveness, enabling more precise interventions and support for users.

Additionally, the increasing popularity of alternative nicotine delivery systems, such as e-cigarettes and heated tobacco products, is reshaping the smoking cessation market. While these products are often marketed as less harmful alternatives, they still pose challenges for public health. As regulatory bodies assess the long-term effects of these alternatives, the smoking cessation market will need to adapt, offering comprehensive solutions that address the diverse needs of individuals seeking to quit. The smoking cessation and nicotine de-addiction market is thus positioned for significant growth, driven by innovation, technology, and a collective commitment to improving public health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Nicotine Replacement Therapy
  • Drug Therapy
  • E-cigarettes

By Form

  • Gum
  • Inhaler
  • Tablet
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Online
  • Drug Stores and Retail Pharmacies

COMPANIES PROFILED

  • Rusan Pharma Ltd, Dr Reddys Laboratories Ltd, Imperial Brands Plc, Zydus Group, British American Tobacco Plc, Perrigo Company Plc, Johnson and Johnson Inc, Njoy LLC, Cipla Ltd, GlaxoSmithKline Plc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Nicotine Replacement Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drug Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. E-cigarettes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY FORM 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Form
  • 5.2. Gum Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Inhaler Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Tablet Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Distribution Channel
  • 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Drug Stores and Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Form
    • 7.2.3 By Distribution Channel
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Form
    • 7.3.3 By Distribution Channel
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Form
    • 7.4.3 By Distribution Channel
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Form
    • 7.5.3 By Distribution Channel
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Form
    • 7.6.3 By Distribution Channel
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Rusan Pharma Ltd
    • 9.2.2 Dr. Reddy'S Laboratories Ltd
    • 9.2.3 Imperial Brands Plc
    • 9.2.4 Zydus Group
    • 9.2.5 British American Tobacco Plc
    • 9.2.6 Perrigo Company Plc
    • 9.2.7 Johnson And Johnson Inc
    • 9.2.8 Njoy LLC
    • 9.2.9 Cipla Ltd
    • 9.2.10 GlaxoSmithKline Plc